Attivare therapeutics to present preclinical data for att-01 and att-02 at the american association for cancer research (aacr) annual meeting 2025

Natick, mass.--(business wire)--attivare therapeutics to present preclinical data for att-01 and att-02 at the american association for cancer research (aacr) annual meeting 2025.
T Ratings Summary
T Quant Ranking